LUNGSEARCH: Lung Cancer Screening, Early Detection, Biomarkers and New Therapeutic Targets
SEARCH
![Foto de LUNGSEARCH: Lung Cancer Screening, Early Detection, Biomarkers and New Therapeutic Targets](/img/uploaded/7b51d3b6538129de09fa574a0afe7887.jpg)
![Foto de GlaxoSmithKline (United Kingdom)](/img/noimage_org.png)
GlaxoSmithKline (United Kingdom)
Londres, Reino UnidoPublicacions en col·laboració amb investigadors/es de GlaxoSmithKline (United Kingdom) (6)
2024
-
Triple Therapy and Clinical Control in B+ COPD Patients: A Pragmatic, Prospective, Randomized Trial
Archivos de Bronconeumologia, Vol. 60, Núm. 7, pp. 417-422
2017
-
Redefining Cut-Points for High Symptom Burden of the Global Initiative for Chronic Obstructive Lung Disease Classification in 18,577 Patients With Chronic Obstructive Pulmonary Disease
Journal of the American Medical Directors Association, Vol. 18, Núm. 12, pp. 1097.e11-1097.e24
2012
-
Inflammatory and repair serum biomarker pattern. Association to clinical outcomes in COPD
Respiratory Research, Vol. 13
2008
-
C-reactive protein levels and survival in patients with moderate to very severe COPD
Chest, Vol. 133, Núm. 6, pp. 1336-1343
2005
1995
-
Neuronal nitric oxide synthase immunoreactivity in the respiratory tract of the frog, Rana temporaria
The Histochemical Journal, Vol. 27, Núm. 10, pp. 812-818